AHA is among the investors and partners taking part in a first-of-its-kind movement to promote equity in access to capital for investments in Black-founded and -led companies at the forefront of health care innovation. 

Jumpstart Health Investors today  Jumpstart Nova, a $55 million oversubscribed fund that will invest exclusively in Black founded-and-led health care companies across health IT, digital health, tech-enabled services, diagnostic devices, biotech, medical device manufacturing and consumer health and wellness sectors. The companies within the fund will be startups focused on developing solutions to improve access, affordability and outcomes in communities of need.

AHA is joined by HCA Healthcare, Atrium Health, Henry Ford Health System and LHC Group among the fund鈥檚 investors and strategic health care partners.

鈥淗ospitals and health systems need strong partners to collaborate with to build healthier and more equitable communities,鈥 said AHA President and CEO Rick Pollack. 鈥淛umpstart Nova aims to provide talented but too-often overlooked entrepreneurs with the capital they need to advance this important work. The AHA is excited about the investments this fund will make, which we believe can positively affect the double bottom-line of financial and social impact.鈥

Related News Articles

Headline
The Senate July 29 voted 51-47 along party lines to confirm Susan Monarez as the new director of the Centers for Disease Control and Prevention. Monarez served鈥
Headline
The American Society for Health Care Engineering July 28 announced the recipients of its annual member awards during the 2025 Health Care Facilities Innovation鈥
Perspective
Public
The 2025 AHA Leadership Summit wrapped up on July 22, and as always, it was energizing and inspiring to connect with so many talented and dedicated people鈥
Headline
The AHA July 14 responded to a Department of Health and Human Services request for information regarding lawful regulation and innovation to promote better鈥
Perspective
Public
Personalized cancer vaccines that are tailored to individual patients, targeting the specific mutations present in their tumors.AI analysis of pathology slides鈥
Headline
Duke University鈥檚 Anna Tharakan, lead project manager on Closing the Gap on Hypertension Disparities, and Bradi Granger, Ph.D., research professor at Duke鈥